002-01 (87441 002 01 Converted)
This text provides information about Buprenorphine and Naloxone sublingual tablets with a dosage of 8mg Buprenorphine HCI USP and 2mg Naloxone HCI dihydrate USP. It includes directions for storage and dispensing and mentions the importance of keeping the medication out of reach of children to prevent accidental ingestion. The tablets are intended for prescription use only. For complete prescribing information, refer to the insert provided with the product.*